Was The Mass. Pharmacy Board Lenient On Firm Tied To Meningitis Outbreak?

09:31

October 25, 2012

We discuss the new evidence that the Massachusetts Board of Registration in Pharmacy may have been lenient on the Framingham compounding pharmacy responsible for the national meningitis outbreak that’s caused more than 20 deaths. We'll examine the state records in closer detail.

Guest:

Kay Lazar, health reporter for The Boston Globe

More:

State Moves To Revoke License Of Pharmacy Linked To Meningitis Outbreak
Boston Globe: Mass. board was lenient on drug maker
Department of Public Health: NECC Preliminary Investigation Findings

This segment aired on October 25, 2012.